Rare diseases
Investigational molecules
Locations
Back to Czechia4 clinical trials in Latran, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)CzechiaA study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.
CzechiaStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
CzechiaStudy on the Effects of Itepekimab for Patients with Non-Cystic Fibrosis Bronchiectasis
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on atherosclerotic cardiovascular disease (ASCVD) prevention and treatment. The studies aim to evaluate new therapeutic approaches for reducing cardiovascular events in high-risk patients.
These trials explore promising treatments for patients with elevated LDL cholesterol levels who are at risk of serious cardiovascular events.
Groundbreaking studies in non-cystic fibrosis bronchiectasis (NCFB) are evaluating novel therapeutic approaches using targeted antibody treatments.
The research focuses on developing innovative treatments to reduce pulmonary exacerbations and improve quality of life for patients with bronchiectasis.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
